Cytosine Deaminase-Overexpressing hTERT-Immortalized Human Adipose Stem Cells Enhance the Inhibitory Effects of Fluorocytosine on Tumor Growth in Castration Resistant Prostate Cancer
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25105519 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Jae Heon Kim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Soonchunhyang University School of Medicine, Seoul 04401, Republic of Korea. Hauptthemen laut MEDLINE: Cytosine Deaminase, Flucytosine, Prostatic Neoplasms, Castration-Resistant, Telomerase. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Soonchunhyang University, Soonchunhyang University Research Fund and the National Research Foundation of Korea (NRF).
Abstract (Originalsprache)
A promising de novo approach for the treatment of Castration-resistant prostate cancer (CRPC) exploits cell-mediated enzyme prodrug therapy comprising cytosine deaminase (CD) and fluorouracil (5-FC). The aim of this study was to determine the potential of bacterial CD-overexpressing hTERT-immortalized human adipose stem cells (hTERT-ADSC.CD) to suppress CRPC. A lentiviral vector encoding a bacterial CD gene was used to transfect and to generate the hTERT-ADSC.CD line. The ability of the cells to migrate selectively towards malignant cells was investigated in vitro. PC3 and hTERT-ADSC.CD cells were co-cultured. hTERT-ADSC.CD and 1 × 106 PC3 cells were administered to nude mice via intracardiac and subcutaneous injections, respectively, and 5-FC was given for 14 days. hTERT-ADSC.CD were successfully engineered. Enhanced in vitro hTERT-ADSC.CD cytotoxicity and suicide effect were evident following administration of 5 μM 5-FC. hTERT-ADSC.CD, together with 5-FC, augmented the numbers of PC3 cells undergoing apoptosis. In comparison to controls administered hTERT-ADSC.CD monotherapy, hTERT-ADSC.CD in combination with 5-FC demonstrated a greater suppressive effect on tumor. In CPRC-bearing mice, tumor suppression was enhanced by the combination of CD-overexpressing ADSC and the prodrug 5-FC. Stem cells exhibiting CD gene expression are a potential novel approach to treatment for CRPC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Soonchunhyang University School of Medicine, Seoul 04401, Republic of Korea.
- Department of Urology, Soonchunhyang University School of Medicine, Cheonan 31151, Republic of Korea.
- Program in Biomedical Sciences & Engineering, Department of Biomedical Sciences, College of Medicine, Inha University, Incheon 22212, Republic of Korea.
ORCID-Profile: Hee Jo Yang
Förderung
- National Research Foundation of Korea
- Soonchunhyang University
- Soonchunhyang University Research Fund and the National Research Foundation of Korea (NRF)
- Ministry of Education, Science and Technology
Zitieren
APA
Kim, J. H., Yang, H. J., Lee, S. H., & Song, Y. S. (2024). Cytosine Deaminase-Overexpressing hTERT-Immortalized Human Adipose Stem Cells Enhance the Inhibitory Effects of Fluorocytosine on Tumor Growth in Castration Resistant Prostate Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25105519
Vancouver
Kim JH, Yang HJ, Lee SH, Song YS. Cytosine Deaminase-Overexpressing hTERT-Immortalized Human Adipose Stem Cells Enhance the Inhibitory Effects of Fluorocytosine on Tumor Growth in Castration Resistant Prostate Cancer. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25105519
BibTeX
@article{Kim2024,
author = {Kim, Jae Heon and Yang, Hee Jo and Lee, Sang Hun and Song, Yun Seob},
title = {Cytosine Deaminase-Overexpressing hTERT-Immortalized Human Adipose Stem Cells Enhance the Inhibitory Effects of Fluorocytosine on Tumor Growth in Castration Resistant Prostate Cancer},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25105519}
}
EUVIMED